| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.2 |